DRAW-TO-THAW Trademark

Trademark Overview


On Tuesday, December 12, 2023, a trademark application was filed for DRAW-TO-THAW with the United States Patent and Trademark Office. The USPTO has given the DRAW-TO-THAW trademark a serial number of 98309999. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, September 30, 2024. This trademark is owned by New York Blood Center, Inc.. The DRAW-TO-THAW trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, Advertising, Business and Retail Services, Transportation & Storage Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Cryopreservation of human cells

Storage of blood and stem cells for medical use; human stem cell storage for medical use

Products to support and manage transfusion medicine and regenerative medicine from discovery through development and to the clinic, namely, blood plasma, blood for medical purposes, blood products, namely cord blood, leukopaks, buffy coats for medical use, antibody positive blood plasma, blood components for medical purposes, namely, phenotyped red cell units and monoclonal antibodies, cord blood all for use in medical diagnoses and treatment; mononuclear cells for medical use, progenitor cells for medical use, antibody preparations for medical use in medical clinical trials and medical purposes

Providing independent review of clinical trials for business purposes

Products to support and manage cellular therapy related research and clinical programs from discovery through development and to the clinic, namely, blood plasma, blood for medical purposes, blood products, namely cord blood, leukopaks, buffy coats for clinical trial use, antibody positive blood plasma, blood components for medical purposes, namely, phenotyped red cell units and monoclonal antibodies, cord blood all for use in medical and clinical research

Blood bank services; tissue bank services; collection and preservation of human blood, red blood cells, plasma and bone marrow; apheresis, namely, removal, treatment, and processing of human blood; T cell isolation services, namely, medical services involving the removal, treatment, and processing of human blood to isolate t cells

Pharmaceutical research services and conducting pharmaceutical clinical trials for others; medical research laboratory services, namely, cell processing services for use by others
draw-to-thaw

General Information


Serial Number98309999
Word MarkDRAW-TO-THAW
Filing DateTuesday, December 12, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2024

Trademark Statements


Goods and ServicesCryopreservation of human cells
Goods and ServicesStorage of blood and stem cells for medical use; human stem cell storage for medical use
Goods and ServicesProducts to support and manage transfusion medicine and regenerative medicine from discovery through development and to the clinic, namely, blood plasma, blood for medical purposes, blood products, namely cord blood, leukopaks, buffy coats for medical use, antibody positive blood plasma, blood components for medical purposes, namely, phenotyped red cell units and monoclonal antibodies, cord blood all for use in medical diagnoses and treatment; mononuclear cells for medical use, progenitor cells for medical use, antibody preparations for medical use in medical clinical trials and medical purposes
Goods and ServicesProviding independent review of clinical trials for business purposes
Goods and ServicesProducts to support and manage cellular therapy related research and clinical programs from discovery through development and to the clinic, namely, blood plasma, blood for medical purposes, blood products, namely cord blood, leukopaks, buffy coats for clinical trial use, antibody positive blood plasma, blood components for medical purposes, namely, phenotyped red cell units and monoclonal antibodies, cord blood all for use in medical and clinical research
Goods and ServicesBlood bank services; tissue bank services; collection and preservation of human blood, red blood cells, plasma and bone marrow; apheresis, namely, removal, treatment, and processing of human blood; T cell isolation services, namely, medical services involving the removal, treatment, and processing of human blood to isolate t cells
Goods and ServicesPharmaceutical research services and conducting pharmaceutical clinical trials for others; medical research laboratory services, namely, cell processing services for use by others

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, September 12, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code039
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNew York Blood Center, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew York, NY 10065

Trademark Events


Event DateEvent Description
Tuesday, December 12, 2023NEW APPLICATION ENTERED
Thursday, March 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 11, 2024ASSIGNED TO EXAMINER
Friday, July 19, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 19, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, July 19, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 19, 2024EXAMINERS AMENDMENT E-MAILED
Friday, July 19, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, August 6, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, September 12, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, September 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 12, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, September 12, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 12, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, September 12, 2024EXAMINER'S AMENDMENT ENTERED